We are live on ! Find out more
BNTX icon

BioNTech

282 hedge funds and large institutions have $4.34B invested in BioNTech in 2023 Q4 according to their latest regulatory filings, with 70 funds opening new positions, 91 increasing their positions, 70 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

84% more first-time investments, than exits

New positions opened: 70 | Existing positions closed: 38

30% more repeat investments, than reductions

Existing positions increased: 91 | Existing positions reduced: 70

12% more funds holding

Funds holding: 252282 (+30)

8% more capital invested

Capital invested by funds: $4.01B → $4.34B (+$330M)

1.92% more ownership

Funds ownership: 15.42%17.33% (+1.9%)

5% more call options, than puts

Call options by funds: $234M | Put options by funds: $224M

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

Holders
282
Holders Change
+30
Holders Change %
+11.9%
% of All Funds
4.11%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
70
Increased
91
Reduced
70
Closed
38
Calls
$234M
Puts
$224M
Net Calls
+$10.8M
Net Calls Change
+$12.2M
Name Holding Trade Value Shares
Change
Change in
Stake
Truist Financial
101
Truist Financial
North Carolina
$1.45M +$1.38M +13,694 New
SSA
102
Schonfeld Strategic Advisors
New York
$1.44M +$1.15M +11,377 +495%
Bank of Montreal
103
Bank of Montreal
Ontario, Canada
$1.39M +$1.32M +13,129 New
LPL Financial
104
LPL Financial
California
$1.34M -$100K -996 -7%
QCM
105
QRG Capital Management
Illinois
$1.33M +$450K +4,466 +55%
CII
106
Capital International Inc
California
$1.29M +$111K +1,104 +10%
AC
107
Aristides Capital
Kentucky
$1.26M +$1.01M +10,000 +526%
YIH
108
Y-Intercept (HK)
Hong Kong
$1.23M +$1.18M +11,696 New
DC
109
Davenport & Co
Virginia
$1.2M +$1.15M +11,406 New
CUAMC
110
China Universal Asset Management Company
China
$1.18M +$880K +8,731 +352%
Commonwealth Equity Services
111
Commonwealth Equity Services
Massachusetts
$1.15M +$26.2K +260 +2%
KeyBank National Association
112
KeyBank National Association
Ohio
$1.12M +$1.07M +10,571 New
S
113
Systrade
Liechtenstein
$1.06M -$4.03M -40,000 -80%
BMSSC
114
B. Metzler seel. Sohn & Co
Germany
$1.05M
Franklin Resources
115
Franklin Resources
California
$1.04M +$622K +6,177 +166%
SG Americas Securities
116
SG Americas Securities
New York
$1.04M -$2.15M -21,367 -68%
BNP Paribas Asset Management
117
BNP Paribas Asset Management
France
$1.01M -$373K -3,698 -28%
Osaic Holdings
118
Osaic Holdings
Arizona
$945K +$75.9K +753 +9%
KPWS
119
Kestra Private Wealth Services
Texas
$938K +$895K +8,883 New
Mercer Global Advisors
120
Mercer Global Advisors
Colorado
$915K +$93.7K +930 +12%
SFA
121
Sequoia Financial Advisors
Ohio
$831K +$793K +7,870 New
JP Morgan Chase
122
JP Morgan Chase
New York
$826K +$711K +7,057 +916%
EGM
123
Engineers Gate Manager
New York
$783K +$748K +7,421 New
Zurich Cantonal Bank
124
Zurich Cantonal Bank
Switzerland
$742K +$2.62K +26 +0.4%
BCM
125
Bayesian Capital Management
New York
$728K +$70.5K +700 +11%

BNTX Hedge Fund Activity: Q4 2023 in Review

282 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in BioNTech (BNTX) for Q4 2023, worth a combined $4.34B — up 8.2% from $4.01B a quarter earlier.

Buyers outnumbered sellers: 70 funds opened new BNTX positions and 38 closed out — a net gain of 32 holders — while 91 added to existing stakes and 70 trimmed.

The largest buyer was Harding Loevner, opening a new position worth an estimated $397M. The largest seller was Artisan Partners, cutting an estimated $67.6M.

  • 282 institutional investors held BioNTech (BNTX) as of Q4 2023, up from 252 in Q3 2023.
  • Funds reported $4.34B of BioNTech stock for Q4 2023, up 8.2% quarter-over-quarter.
  • 70 funds opened new BioNTech positions in Q4 2023 and 38 closed out, a net change of +32 holders.
  • The largest BioNTech buyer in Q4 2023 was Harding Loevner, an estimated $397M added.
  • The largest BioNTech seller in Q4 2023 was Artisan Partners, an estimated $67.6M sold.

Based on aggregated 13F filings for Q4 2023.